Ushikumachi, Japan

Shizuko Ohya


Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1984-1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Shizuko Ohya

Introduction

Shizuko Ohya, an accomplished inventor based in Ushikumachi, Japan, has made significant strides in the field of pharmaceuticals through her innovative research. With a portfolio of two patents to her name, her work primarily focuses on peptides with analgesic properties. Her findings have the potential to transform pain management in medical applications.

Latest Patents

Shizuko Ohya's recent patents showcase her cutting-edge research. One of her notable inventions is the "Analgesic peptide and process for the preparation thereof," which introduces a novel peptide with the primary structure: N-Me-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-D.Ile-Arg-Pro-Lys-D.Leu-Lys-Trp-NH₂. This peptide reveals remarkable analgesic effects when administered peripherally, providing new avenues for pain relief. The patent also outlines a solid-phase method for synthesizing this analgesic peptide.

Another significant patent is the development of a "Heptadecapeptide," which is derived from swine duodenum. This opioid substance comprises a heptadecapeptide with the primary amino acid structure: Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln. The patent highlights its opiate and analgesic activity, paving the way for further research in pain management therapies.

Career Highlights

Shizuko Ohya is currently engaged in her research at Eisai Company, Limited, a global pharmaceutical company. Her dedication and expertise have enabled her to contribute richly to the synthetic biology and pharmaceutical sectors, reflecting her commitment to innovative healthcare solutions.

Collaborations

Throughout her career, Shizuko Ohya has collaborated with fellow scientists, including Shinro Tachibana and Yoshihiro Arakawa. These collaborations have fostered an environment of innovation, enhancing the research outcomes and developing her groundbreaking patents in the pharmacological field.

Conclusion

Shizuko Ohya's contributions to the realm of analgesic peptides are noteworthy and reflect a significant advancement in pain management. Her innovative research, encapsulated in her recent patents, continues to influence the pharmaceutical landscape, offering potential new treatments for pain relief. As she continues her work at Eisai Company, Limited, the medical community eagerly anticipates the impact of her future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…